293 related articles for article (PubMed ID: 16929622)
21. Imaging of hepatocellular carcinoma: current concepts.
Parikh A; Taouli B
Recent Results Cancer Res; 2013; 190():33-55. PubMed ID: 22941012
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular nodules in liver cirrhosis: MR evaluation.
Lee JM; Choi BI
Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975
[TBL] [Abstract][Full Text] [Related]
23. [Epidemiology and diagnosis of hepatocellular carcinomas in cirrhosis].
Duvoux C
Ann Chir; 1998; 52(6):511-7. PubMed ID: 9752500
[TBL] [Abstract][Full Text] [Related]
24. A 70-year-old woman with 10 years of markedly elevated alpha-fetoprotein measurements.
Hsu SX; Siegel AB; Berk PD
Semin Liver Dis; 2010 Feb; 30(1):99-106. PubMed ID: 20175037
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma: Advances in diagnostic imaging.
Sun H; Song T
Drug Discov Ther; 2015 Oct; 9(5):310-8. PubMed ID: 26632539
[TBL] [Abstract][Full Text] [Related]
26. [Screening for hepatocellular carcinoma].
Leone N; Rizzetto M
Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
[TBL] [Abstract][Full Text] [Related]
27. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
[TBL] [Abstract][Full Text] [Related]
28. [Comparative evaluation of echography, computerized tomography and magnetic resonance imaging in the diagnosis of hepatocellular carcinoma in cirrhotic patients].
Dalla Palma L; Pozzi-Mucelli RS; Bazzocchi M; Pozzi-Mucelli R; Ferrara P
Radiol Med; 1991; 81(1-2):8-15. PubMed ID: 1848720
[TBL] [Abstract][Full Text] [Related]
29. Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma.
Manini MA; Sangiovanni A; Fornari F; Piscaglia F; Biolato M; Fanigliulo L; Ravaldi E; Grieco A; Colombo M;
J Hepatol; 2014 May; 60(5):995-1001. PubMed ID: 24462368
[TBL] [Abstract][Full Text] [Related]
30. MRI in detection of hepatocellular carcinoma (HCC).
Digumarthy SR; Sahani DV; Saini S
Cancer Imaging; 2005 Apr; 5(1):20-4. PubMed ID: 16154814
[TBL] [Abstract][Full Text] [Related]
31. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.
Sangiovanni A; Manini MA; Iavarone M; Romeo R; Forzenigo LV; Fraquelli M; Massironi S; Della Corte C; Ronchi G; Rumi MG; Biondetti P; Colombo M
Gut; 2010 May; 59(5):638-44. PubMed ID: 19951909
[TBL] [Abstract][Full Text] [Related]
32. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
[TBL] [Abstract][Full Text] [Related]
33. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations.
Libbrecht L; Bielen D; Verslype C; Vanbeckevoort D; Pirenne J; Nevens F; Desmet V; Roskams T
Liver Transpl; 2002 Sep; 8(9):749-61. PubMed ID: 12200773
[TBL] [Abstract][Full Text] [Related]
34. From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls.
Baron RL; Peterson MS
Radiographics; 2001 Oct; 21 Spec No():S117-32. PubMed ID: 11598252
[TBL] [Abstract][Full Text] [Related]
35. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
36. Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines.
Golfieri R; Garzillo G; Ascanio S; Renzulli M
Dig Dis; 2014; 32(6):696-704. PubMed ID: 25376286
[TBL] [Abstract][Full Text] [Related]
37. Modern diagnosis and management of hepatocellular carcinoma.
Marrero JA; Welling T
Clin Liver Dis; 2009 May; 13(2):233-47. PubMed ID: 19442916
[TBL] [Abstract][Full Text] [Related]
38. Liver cancer in Malaysia: epidemiology and clinical presentation in a multiracial Asian population.
Goh KL; Razlan H; Hartono JL; Qua CS; Yoong BK; Koh PS; Abdullah BJ
J Dig Dis; 2015 Mar; 16(3):152-8. PubMed ID: 25512092
[TBL] [Abstract][Full Text] [Related]
39. Screening and detection of hepatocellular carcinoma.
Simpson HN; McGuire BM
Clin Liver Dis; 2015 May; 19(2):295-307. PubMed ID: 25921664
[TBL] [Abstract][Full Text] [Related]
40. [The diagnostic approach to hepatocellular carcinoma].
Schacherer D; Schoelmerich J; Zuber-Jerger I
Z Gastroenterol; 2007 Oct; 45(10):1067-74. PubMed ID: 17924305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
